Form D · Other Investment Fund
FRX Sensulin LLC
New York, NY · CIK 0001700894
Offering snapshot reported Mar 15, 2017 · SEC filing
- Reported sold
- $40K Offering amount: $40K
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 30, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 15, 2017 | Initial | $40,000 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-282601
Source: Form D, filed Mar 15, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
The linked fund shows its most recently reported ADV details.
Matched by reported Form D file number
FRX SENSULIN LLC
Investment adviser: MBX CAPITAL, LLC
- Gross asset value
- $0
- Beneficial owners
- 6
- ADV minimum commitment
- $5K
Reported in Form ADV on Mar 9, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.
Service providers
Provider details
- Annual audit
- No
- Prime brokers
- No
- Custodians
- No
- Administrator other than the adviser
- Yes
- External marketing
- No
Filing source
Form ADV 2065550 · Mar 9, 2026 · Schedule D 7.B.(1), fund 805-8055769828
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Llc Assure Fund Management Ii | Director |
| Llc Fund Rx Capital Management | Director |
| Mateo Johnson | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:New York, NY, 10006